| Literature DB >> 31033229 |
Michael Dybek1, Jason Wallach2, Pierce V Kavanagh3, Tristan Colestock2, Nadine Filemban2, Geraldine Dowling3,4, Folker Westphal5, Simon P Elliott6, Adeboye Adejare2, Simon D Brandt7.
Abstract
A number of substances based on the 1,2-diarylethylamine template have been investigated for various potential clinical applications whereas others have been encountered as research chemicals sold for non-medical use. Some of these substances have transpired to function as NMDA receptor antagonists that elicit dissociative effects in people who use these substances recreationally. 1-[1-(2-Fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane, 2-F-DPPy) has recently appeared as a research chemical, which users report has dissociative effects. One common difficulty encountered by stakeholders confronting the appearance of new psychoactive substances is the presence of positional isomers. In the case of fluorolintane, the presence of the fluorine substituent on either the phenyl and benzyl moieties of the 1,2-diarylethylamine structure results in a total number of six possible racemic isomers, namely 2-F-, 3-F-, and 4-F-DPPy (phenyl ring substituents) and 2"-F-, 3"-F-, and 4"-F-DPPy (benzyl ring substituents). The present study reports the chemical syntheses and comprehensive analytical characterizations of the two sets of three positional isomers. These studies included various low- and high-resolution mass spectrometry platforms, gas- and liquid chromatography (GC and LC), nuclear magnetic resonance (NMR) spectroscopy and GC-condensed phase and attenuated total reflection infrared spectroscopy analyses. The differentiation between each set of three isomers was possible under a variety of experimental conditions including GC chemical ionization triple quadrupole tandem mass spectrometric analysis of the [M + H - HF]+ species. The latter MS method was particularly helpful as it revealed distinct formations of product ions for each of the six investigated substances.Entities:
Keywords: 1,2-diarylethylamines; NMDA receptor; dissociatives; forensic; new psychoactive substances
Mesh:
Substances:
Year: 2019 PMID: 31033229 DOI: 10.1002/dta.2608
Source DB: PubMed Journal: Drug Test Anal ISSN: 1942-7603 Impact factor: 3.345